ReP USP - Resultado da busca

Filtros : "IQ005" "DIABETES MELLITUS" "2016" Removidos: "História Social" "ODM" "PST" "Coreano" Limpar

Filtros

Artigo de periodico
Diluted serum from calorie-restricted animals promotesmitochondrial β-cell adaptations and protect against glucolipotoxicity (2016)
Cerqueira, Fernanda Menezes; Chausse, Bruno; Baranovski, Boris M; Liesa, Marc; Lewis, Eli C; Shirihai, Orian S; Kowaltowski, Alicia Juliana
Source: Febbs Journal. Unidade: IQ
Subjects: DIABETES MELLITUS, MITOCÔNDRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERQUEIRA, Fernanda Menezes et al. Diluted serum from calorie-restricted animals promotesmitochondrial β-cell adaptations and protect against glucolipotoxicity. Febbs Journal, v. 283, n. 5, p. 822-833, 2016Tradução . . Disponível em: https://doi.org/10.1111/febs.13632. Acesso em: 30 jun. 2024.
APA
Cerqueira, F. M., Chausse, B., Baranovski, B. M., Liesa, M., Lewis, E. C., Shirihai, O. S., & Kowaltowski, A. J. (2016). Diluted serum from calorie-restricted animals promotesmitochondrial β-cell adaptations and protect against glucolipotoxicity. Febbs Journal, 283( 5), 822-833. doi:10.1111/febs.13632
NLM
Cerqueira FM, Chausse B, Baranovski BM, Liesa M, Lewis EC, Shirihai OS, Kowaltowski AJ. Diluted serum from calorie-restricted animals promotesmitochondrial β-cell adaptations and protect against glucolipotoxicity [Internet]. Febbs Journal. 2016 ; 283( 5): 822-833.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1111/febs.13632
Vancouver
Cerqueira FM, Chausse B, Baranovski BM, Liesa M, Lewis EC, Shirihai OS, Kowaltowski AJ. Diluted serum from calorie-restricted animals promotesmitochondrial β-cell adaptations and protect against glucolipotoxicity [Internet]. Febbs Journal. 2016 ; 283( 5): 822-833.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1111/febs.13632
Artigo de periodico
Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone (2016)
Ronsein, Graziella Eliza ; Reyes Soffer, Gissette; He, Yi; Oda, Michael; Ginsberg, Henry; Heinecke, Jay W
Source: Molecular e Cellular Proteomics. Unidade: IQ
Subjects: APOLIPOPROTEÍNAS, LIPOPROTEÍNAS HDL, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RONSEIN, Graziella Eliza et al. Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone. Molecular e Cellular Proteomics, v. 15, n. 3, p. 1083-1093, 2016Tradução . . Disponível em: https://doi.org/10.1074/mcp.M115.054528. Acesso em: 30 jun. 2024.
APA
Ronsein, G. E., Reyes Soffer, G., He, Y., Oda, M., Ginsberg, H., & Heinecke, J. W. (2016). Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone. Molecular e Cellular Proteomics, 15( 3), 1083-1093. doi:10.1074/mcp.M115.054528
NLM
Ronsein GE, Reyes Soffer G, He Y, Oda M, Ginsberg H, Heinecke JW. Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone [Internet]. Molecular e Cellular Proteomics. 2016 ; 15( 3): 1083-1093.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1074/mcp.M115.054528
Vancouver
Ronsein GE, Reyes Soffer G, He Y, Oda M, Ginsberg H, Heinecke JW. Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone [Internet]. Molecular e Cellular Proteomics. 2016 ; 15( 3): 1083-1093.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1074/mcp.M115.054528

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024